PRJNA549038
Cas9-targeted long read sequencing of cancers
We explored the feasibility of single-molecule nanopore sequencing technology to comprehensively and simultaneously assess the mutations and methylation status. We designed a CRISPR-Cas9 system to cut desired DNA fragments and perform sequencing, with no need for amplification.